Literature DB >> 19211564

Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2.

Darja Bamming1, Curt M Horvath.   

Abstract

Intracellular pattern recognition receptors MDA5, RIG-I, and LGP2 are essential components of the cellular response to virus infection and are homologous to the DEXH box subfamily of RNA helicases. However, the relevance of helicase activity in the regulation of interferon production remains elusive. To examine the importance of the helicase domain function for these signaling proteins, a series of mutations targeting conserved helicase sequence motifs were analyzed for enzymatic activity, RNA binding, interferon induction, and antiviral signaling. Results indicate that all targeted motifs are required for ATP hydrolysis, but a subset is involved in RNA binding. The enzymatically inactive mutants differed in their signaling ability. Notably, mutations to MDA5 motifs I, III, and VI and RIG-I motif III produced helicase proteins with constitutive antiviral activity, whereas mutations in RIG-I motif V retained ATP hydrolysis but failed to mediate signal transduction. These findings demonstrate that type I interferon production mediated by full-length MDA5 and RIG-I is independent of the helicase domain catalytic activity. In addition, neither enzymatic activity nor RNA binding was required for negative regulation of antiviral signaling by LGP2, supporting an RNA-independent interference mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211564      PMCID: PMC2665091          DOI: 10.1074/jbc.M807365200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Sendai virus defective-interfering genomes and the activation of interferon-beta.

Authors:  Laura Strahle; Dominique Garcin; Daniel Kolakofsky
Journal:  Virology       Date:  2006-05-02       Impact factor: 3.616

2.  Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif.

Authors:  Supriya K Saha; Eric M Pietras; Jeannie Q He; Jason R Kang; Su-Yang Liu; Gagik Oganesyan; Arash Shahangian; Brian Zarnegar; Travis L Shiba; Yao Wang; Genhong Cheng
Journal:  EMBO J       Date:  2006-07-06       Impact factor: 11.598

3.  5'-Triphosphate RNA is the ligand for RIG-I.

Authors:  Veit Hornung; Jana Ellegast; Sarah Kim; Krzysztof Brzózka; Andreas Jung; Hiroki Kato; Hendrik Poeck; Shizuo Akira; Karl-Klaus Conzelmann; Martin Schlee; Stefan Endres; Gunther Hartmann
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

4.  Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.

Authors:  Takeshi Saito; Reiko Hirai; Yueh-Ming Loo; David Owen; Cynthia L Johnson; Sangita C Sinha; Shizuo Akira; Takashi Fujita; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-26       Impact factor: 11.205

5.  RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2.

Authors:  Akihiko Komuro; Curt M Horvath
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

6.  RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.

Authors:  Andreas Pichlmair; Oliver Schulz; Choon Ping Tan; Tanja I Näslund; Peter Liljeström; Friedemann Weber; Caetano Reis e Sousa
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

7.  Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses.

Authors:  Thiagarajan Venkataraman; Maikel Valdes; Rachel Elsby; Shigeru Kakuta; Gisela Caceres; Shinobu Saijo; Yoichiro Iwakura; Glen N Barber
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

8.  Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity.

Authors:  Yueh-Ming Loo; Jamie Fornek; Nanette Crochet; Gagan Bajwa; Olivia Perwitasari; Luis Martinez-Sobrido; Shizuo Akira; Michelle A Gill; Adolfo García-Sastre; Michael G Katze; Michael Gale
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

9.  Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3.

Authors:  Chul Hyun Joo; Young C Shin; Michaela Gack; Liguo Wu; David Levy; Jae U Jung
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

10.  The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I.

Authors:  Sheng Cui; Katharina Eisenächer; Axel Kirchhofer; Krzysztof Brzózka; Alfred Lammens; Katja Lammens; Takashi Fujita; Karl-Klaus Conzelmann; Anne Krug; Karl-Peter Hopfner
Journal:  Mol Cell       Date:  2008-02-01       Impact factor: 17.970

View more
  92 in total

1.  Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition.

Authors:  Alys Peisley; Cecilie Lin; Bin Wu; McGhee Orme-Johnson; Mengyuan Liu; Thomas Walz; Sun Hur
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  The RIG-I ATPase domain structure reveals insights into ATP-dependent antiviral signalling.

Authors:  Filiz Civril; Matthew Bennett; Manuela Moldt; Tobias Deimling; Gregor Witte; Stefan Schiesser; Thomas Carell; Karl-Peter Hopfner
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

Review 3.  Pattern recognition of viral nucleic acids by RIG-I-like helicases.

Authors:  Andreas Schmidt; Stefan Endres; Simon Rothenfusser
Journal:  J Mol Med (Berl)       Date:  2010-09-04       Impact factor: 4.599

4.  Dissociation of paramyxovirus interferon evasion activities: universal and virus-specific requirements for conserved V protein amino acids in MDA5 interference.

Authors:  Aparna Ramachandran; Curt M Horvath
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

5.  Paramyxovirus V proteins interact with the RNA Helicase LGP2 to inhibit RIG-I-dependent interferon induction.

Authors:  Kay Childs; Richard Randall; Stephen Goodbourn
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

6.  Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.

Authors:  Chi-You Chang; Helene Minyi Liu; Ming-Fu Chang; Shin C Chang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 7.  Effects of type 1 diabetes-associated IFIH1 polymorphisms on MDA5 function and expression.

Authors:  Benjamin M Looney; Chang-Qing Xia; Patrick Concannon; David A Ostrov; Michael J Clare-Salzler
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

8.  MDA5 assembles into a polar helical filament on dsRNA.

Authors:  Ian C Berke; Xiong Yu; Yorgo Modis; Edward H Egelman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

9.  RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation.

Authors:  Ryan C Widau; Akash D Parekh; Mark C Ranck; Daniel W Golden; Kiran A Kumar; Ravi F Sood; Sean P Pitroda; Zhengkai Liao; Xiaona Huang; Thomas E Darga; David Xu; Lei Huang; Jorge Andrade; Bernard Roizman; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

10.  RIG-I Uses an ATPase-Powered Translocation-Throttling Mechanism for Kinetic Proofreading of RNAs and Oligomerization.

Authors:  Swapnil C Devarkar; Brandon Schweibenz; Chen Wang; Joseph Marcotrigiano; Smita S Patel
Journal:  Mol Cell       Date:  2018-09-27       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.